Meta-analysis of stem cell therapy in chronic ischemic cardiomyopathy

American Journal of Cardiology

Volumn 112, Issue 2, 2013, Pages 217-225

  Kandala, Jagdesh ^a   Upadhyay, Gaurav A ^a   Pokushalov, Evgeny ^b   Wu, Sean ^a   Drachman, Douglas E ^a   Singh, Jagmeet P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MESHALKIN NATIONAL MEDICAL RESEARCH CENTER   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW STEM CELL TRANSPLANTATION; CHRONIC ISCHEMIC CARDIOMYOPATHY; CORONARY ARTERY BYPASS GRAFT; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC CARDIOMYOPATHY; KIDNEY FAILURE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STEM CELL TRANSPLANTATION; SYSTOLIC DYSFUNCTION; THERAPY EFFECT;

CHRONIC DISEASE; HUMANS; MYOCARDIAL ISCHEMIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEM CELL TRANSPLANTATION;

EID: 84879838335     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.03.021     Document Type: Article

References (27)

1. D.M. Clifford, S.A. Fisher, S.J. Brunskill, C. Doree, A. Mathur, S. Watt, and E. Martin-Rendon Stem cell treatment for acute myocardial infarction Cochrane Database Syst Rev 2 2012 CD006536
2. E.C. Perin, J.T. Willerson, C.J. Pepine, T.D. Henry, S.G. Ellis, D.X. Zhao, G.V. Silva, D. Lai, J.D. Thomas, M.W. Kronenberg, A.D. Martin, R.D. Anderson, J.H. Traverse, M.S. Penn, S. Anwaruddin, A.K. Hatzopoulos, A.P. Gee, D.A. Taylor, C.R. Cogle, D. Smith, L. Westbrook, J. Chen, E. Handberg, R.E. Olson, C. Geither, S. Bowman, J. Francescon, S. Baraniuk, L.B. Piller, L.M. Simpson, C. Loghin, D. Aguilar, S. Richman, C. Zierold, J. Bettencourt, S.L. Sayre, R.W. Vojvodic, S.I. Skarlatos, D.J. Gordon, R.F. Ebert, M. Kwak, L.A. Moye, and R.D. Simari Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN Trial JAMA 307 2012 1717 1726
3. K.L. Ang, D. Chin, F. Leyva, P. Foley, C. Kubal, S. Chalil, L. Srinivasan, L. Bernhardt, S. Stevens, L.T. Shenje, and M. Galinanes Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone Nat Clin Pract Cardiovasc Med 5 2008 663 670
4. A.N. Patel, L. Geffner, R.F. Vina, J. Saslavsky, H.C. Urschel Jr., R. Kormos, and F. Benetti Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study J Thorac Cardiovasc Surg 130 2005 1631 1638
5. A. Abdel-Latif, R. Bolli, I.M. Tleyjeh, V.M. Montori, E.C. Perin, C.A. Hornung, E.K. Zuba-Surma, M. Al-Mallah, and B. Dawn Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis Arch Intern Med 167 2007 989 997
6. S. Singh, R. Arora, K. Handa, A. Khraisat, N. Nagajothi, J. Molnar, and S. Khosla Stem cells improve left ventricular function in acute myocardial infarction Clin Cardiol 32 2009 176 180
7. Y. Wen, L. Meng, J. Xie, and J. Ouyang Direct autologous bone marrow-derived stem cell transplantation for ischemic heart disease: a meta-analysis Expert Opin Biol Ther 11 2011 559 567
8. C.J. Pepine, and W.W. Nichols The pathophysiology of chronic ischemic heart disease Clin Cardiol 30 2007 I4 I9
9. P. Juni, D.G. Altman, and M. Egger Systematic reviews in health care: assessing the quality of controlled clinical trials BMJ 323 2001 42 46
10. E.C. Perin, G.V. Silva, T.D. Henry, M.G. Cabreira-Hansen, W.H. Moore, S.A. Coulter, J.P. Herlihy, M.R. Fernandes, B.Y. Cheong, S.D. Flamm, J.H. Traverse, Y. Zheng, D. Smith, S. Shaw, L. Westbrook, R. Olson, D. Patel, A. Gahremanpour, J. Canales, W.K. Vaughn, and J.T. Willerson A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF) Am Heart J 161 2011 1078 1087
11. E. Pokushalov, A. Romanov, A. Chernyavsky, P. Larionov, I. Terekhov, S. Artyomenko, O. Poveshenko, E. Kliver, N. Shirokova, A. Karaskov, and N. Dib Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study J Cardiovasc Transl Res 3 2010 160 168
12. Q. Zhao, Y. Sun, L. Xia, A. Chen, and Z. Wang Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery Ann Thorac Surg 86 2008 1833 1840
13. S.P. Hozo, B. Djulbegovic, and I. Hozo Estimating the mean and variance from the median, range, and the size of a sample BMC Med Res Methodol 5 2005 13
14. C. Stamm, H.D. Kleine, Y.H. Choi, S. Dunkelmann, J.A. Lauffs, B. Lorenzen, A. David, A. Liebold, C. Nienaber, D. Zurakowski, M. Freund, and G. Steinhoff Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies J Thorac Cardiovasc Surg 133 2007 717 725
15. B. Assmus, J. Honold, V. Schachinger, M.B. Britten, U. Fischer-Rasokat, R. Lehmann, C. Teupe, K. Pistorius, H. Martin, N.D. Abolmaali, T. Tonn, S. Dimmeler, and A.M. Zeiher Transcoronary transplantation of progenitor cells after myocardial infarction N Engl J Med 355 2006 1222 1232
16. M. Hendrikx, K. Hensen, C. Clijsters, H. Jongen, R. Koninckx, E. Bijnens, M. Ingels, A. Jacobs, R. Geukens, P. Dendale, J. Vijgen, D. Dilling, P. Steels, U. Mees, and J.L. Rummens Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial Circulation 114 2006 I101 I107
17. E.C. Perin, H.F. Dohmann, R. Borojevic, S.A. Silva, A.L. Sousa, C.T. Mesquita, M.I. Rossi, A.C. Carvalho, H.S. Dutra, H.J. Dohmann, G.V. Silva, L. Belem, R. Vivacqua, F.O. Rangel, R. Esporcatte, Y.J. Geng, W.K. Vaughn, J.A. Assad, E.T. Mesquita, and J.T. Willerson Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure Circulation 107 2003 2294 2302
18. S. Hu, S. Liu, Z. Zheng, X. Yuan, L. Li, M. Lu, R. Shen, F. Duan, X. Zhang, J. Li, X. Liu, Y. Song, W. Wang, S. Zhao, Z. He, H. Zhang, K. Yang, W. Feng, and X. Wang Isolated coronary artery bypass graft combined with bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: a single-center, randomized, double-blind, placebo-controlled clinical trial J Am Coll Cardiol 57 2011 2409 2415
19. S. Dimmeler, J. Burchfield, and A.M. Zeiher Cell-based therapy of myocardial infarction Arterioscler Thromb Vasc Biol 28 2008 208 216
20. A.A. Kocher, M.D. Schuster, M.J. Szabolcs, S. Takuma, D. Burkhoff, J. Wang, S. Homma, N.M. Edwards, and S. Itescu Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function Nat Med 7 2001 430 436
21. C. Urbich, and S. Dimmeler Endothelial progenitor cells: characterization and role in vascular biology Circ Res 95 2004 343 353
22. H.F. Tse, C.W. Siu, S.G. Zhu, L. Songyan, Q.Y. Zhang, W.H. Lai, Y.L. Kwong, J. Nicholls, and C.P. Lau Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium Eur J Heart Fail 9 2007 747 753
23. K. Le Blanc Mesenchymal stromal cells: tissue repair and immune modulation Cytotherapy 8 2006 559 561
24. R. Passier, L.W. van Laake, and C.L. Mummery Stem-cell-based therapy and lessons from the heart Nature 453 2008 322 329
25. N. Dib, H. Khawaja, S. Varner, M. McCarthy, and A. Campbell Cell therapy for cardiovascular disease: a comparison of methods of delivery J Cardiovasc Transl Res 4 2011 177 181
26. S.J. Brunskill, C.J. Hyde, C.J. Doree, S.M. Watt, and E. Martin-Rendon Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease Eur J Heart Fail 11 2009 887 896
27. D. Hou, E.A. Youssef, T.J. Brinton, P. Zhang, P. Rogers, E.T. Price, A.C. Yeung, B.H. Johnstone, P.G. Yock, and K.L. March Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials Circulation 112 2005 I150 I156